We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$558M
AUM Growth
+$80.9M
(+17%)
Cap. Flow
+$74.9M
Cap. Flow
% of AUM
13.41%
Top 10 Holdings %
Top 10 Hldgs %
4.09%
Holding
1,998
New
778
Increased
301
Reduced
272
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$3.2M |
| 2 |
Boeing
BA
|
+$2.64M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.42M |
| 4 |
Amgen
AMGN
|
+$2.03M |
| 5 |
Elevance Health
ELV
|
+$1.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.64M |
| 2 |
Lockheed Martin
LMT
|
+$2.31M |
| 3 |
Cigna
CI
|
+$2.21M |
| 4 |
Wells Fargo
WFC
|
+$2.18M |
| 5 |
Paychex
PAYX
|
+$1.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Healthcare | 15.64% |
| 3 | Consumer Discretionary | 14.34% |
| 4 | Industrials | 14.21% |
| 5 | Financials | 12.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Incyte
INCY
$23.7B
| $457K | 0.08% |
7,341
-6,995
| -49% | -$468K |
|
|
PYCR
427
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $457K | 0.08% |
+19,301
| New | +$450K |
|
428
Natera
NTRA
$37B
| $457K | 0.08% |
+9,386
| New | +$479K |
|
429
Adobe
ADBE
$94.5B
| $457K | 0.08% |
+934
| New | +$376K |
|
430
Jack in the Box
JACK
$299M
| $456K | 0.08% |
4,675
+1,258
| +37% | +$114K |
|
|
ASRT
431
DELISTED
Assertio
ASRT
| $455K | 0.08% |
+5,597
| New | +$520K |
|
432
Reinsurance Group of America
RGA
$15.7B
| $454K | 0.08% |
+3,270
| New | +$465K |
|
433
eHealth
EHTH
$43.2M
| $453K | 0.08% |
56,319
+13,431
| +31% | +$107K |
|
434
Idacorp
IDA
$8.2B
| $453K | 0.08% |
4,411
+77
| +2% | +$8.28K |
|
435
Integra LifeSciences
IART
$1.52B
| $451K | 0.08% |
+10,965
| New | +$528K |
|
436
Northern Trust
NTRS
$22.4B
| $450K | 0.08% |
+6,075
| New | +$466K |
|
437
Titan International
TWI
$519M
| $449K | 0.08% |
39,133
-330
| -0.8% | -$3.5K |
|
438
Zoom
ZM
$26.7B
| $449K | 0.08% |
+6,612
| New | +$442K |
|
439
Lincoln Electric
LECO
$14.1B
| $447K | 0.08% |
2,248
-416
| -16% | -$72.5K |
|
440
Red Rock Resorts
RRR
$3.8B
| $445K | 0.08% |
9,512
+2,329
| +32% | +$108K |
|
441
Ligand Pharmaceuticals
LGND
$5.96B
| $444K | 0.08% |
6,161
+2,220
| +56% | +$167K |
|
442
ADC Therapeutics
ADCT
$145M
| $444K | 0.08% |
206,367
-59,892
| -22% | -$135K |
|
|
RVNC
443
DELISTED
Revance Therapeutics, Inc.
RVNC
| $444K | 0.08% |
17,526
+7,311
| +72% | +$228K |
|
444
Sibanye-Stillwater
SBSW
$6.05B
| $443K | 0.08% |
71,042
+44,190
| +165% | +$349K |
|
|
GAP
445
The Gap Inc
GAP
$7.07B
| $443K | 0.08% |
49,605
-33,051
| -40% | -$295K |
|
446
Affirm
AFRM
$24.5B
| $442K | 0.08% |
+28,824
| New | +$382K |
|
447
Roblox
RBLX
$34.7B
| $442K | 0.08% |
+10,962
| New | +$440K |
|
448
Babcock & Wilcox
BW
$1.4B
| $441K | 0.08% |
74,785
-19,166
| -20% | -$112K |
|
449
TETRA Technologies
TTI
$1.14B
| $441K | 0.08% |
130,471
+48,777
| +60% | +$141K |
|
450
Coupang
CPNG
$28.6B
| $440K | 0.08% |
+25,301
| New | +$412K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q2 2023 Portfolio in Review
As of Q2 2023, XTX Topco held 1,998 positions worth $558M, up 17% from $477M the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.
XTX Topco deployed $74.9M of net new capital in Q2 2023, opening 778 new positions and adding to 301 existing holdings. Its largest new stake was Target: 21,561 shares worth $2.84M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lockheed Martin, an estimated $2.31M trimmed.
- XTX Topco's largest Q2 2023 buy was Target: 21,561 shares worth $2.84M.
- XTX Topco added most to Alphabet (Google) Class A in Q2 2023, an estimated $2.42M increase.
- XTX Topco's biggest Q2 2023 reduction was Lockheed Martin, cutting an estimated $2.31M.
- XTX Topco fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $2.64M.
- XTX Topco's ten largest holdings make up 4.1% of its $558M portfolio in Q2 2023.
- XTX Topco opened 778 new positions and closed 643 in Q2 2023.
- XTX Topco's portfolio value rose 17% quarter-over-quarter to $558M.
Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.